629 Neoadjuvant nivolumab combined with CCR2/5 inhibitor or anti-IL-8 antibody in non-small cell lung cancer and hepatocellular carcinoma
Autor: | Nicholas Venturini, Thomas Marron, Maria Casanova-Acebes, John Mandeli, Deborah Doroshow, Natalie Lucas, Kathy Wu, Olivia Hapanowicz, Paula King, Pauline Hamon, Jessica Le Berichel, Diane Del Valle, Clotilde Hennequin, Seunghee Kim-Schulze, Sacha Gnjatic, Miriam Merad, Zhen Zhao, Stephen Ward, Maria Isabel Fiel, Mary Beasley, Edward Kim, Kirema Garcia-Reyes, Udit Chaddha, Timothy Harkin, David Yankelevitz, Ganesh Gunasekaran, Parissa Tabrizian, Myron Schwartz, Andrew Kaufman, Daniel Nicastri, Andrew Wolf, Raja Flores |
---|---|
Rok vydání: | 2022 |
Zdroj: | Regular and Young Investigator Award Abstracts. |
DOI: | 10.1136/jitc-2022-sitc2022.0629 |
Databáze: | OpenAIRE |
Externí odkaz: |